Trial for treating spina bifida in the womb shows remarkable results
Early trials of a breakthrough stem cell therapy to treat babies with spina bifida while still in the womb is showing remarkable results. The trial results published today in The Lancet medical journal show babies who were treated with cells from the mother's placenta were born with no signs of infection, abnormal tissue growth or tumour formation. Associate Professor Lana McClements from the University of Technology in Sydney is one of those who has been watching closely, and she spoke to Melissa Chan-Green.
Checkpoint · RNZ
February 27, 20265m 8s
Audio is streamed directly from the publisher (flex.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Early trials of a breakthrough stem cell therapy to treat babies with spina bifida while still in the womb is showing remarkable results. The trial results published today in The Lancet medical journal show babies who were treated with cells from the mother's placenta were born with no signs of infection, abnormal tissue growth or tumour formation. Associate Professor Lana McClements from the University of Technology in Sydney is one of those who has been watching closely, and she spoke to Melissa Chan-Green.
Topics
healthsciencetechnology